{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:32:53Z","timestamp":1789824773387,"version":"4.0.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":3200,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001070"],"award-info":[{"award-number":["UL1TR001070"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008788","name":"The Ohio State University College of Veterinary Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) is associated with hyperphosphatemia, decreased vitamin D metabolite concentrations, and hyperparathyroidism. This syndrome is known as CKD-mineral bone disorder (CKD-MBD). Recently, it has been shown that an increase in fibroblast growth factor-23 (FGF-23) concentration is an early biomarker of CKD in people. It is an independent risk factor for both progression of renal disease and survival time in humans and cats with CKD. Information about FGF-23 in healthy dogs and those with CKD is lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To measure FGF-23 concentration in dogs with different stages of CKD and determine its association with factors involved in CKD-MBD, including serum phosphorus and parathyroid hormone (PTH) concentrations. A secondary aim was to validate an ELISA for measurement of plasma FGF-23 concentration in dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Thirty-two client-owned dogs with naturally occurring CKD and 10 healthy control dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective cross-sectional study. An FGF-23 ELISA was used to measure plasma FGF-23 concentration in dogs and their association with serum creatinine, phosphorus, calcium, and PTH concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Plasma FGF-23 concentrations increased with severity of CKD and were significantly different between IRIS stages 1 and 2 versus stages 3 and 4 (P &amp;lt; .0001). Increases in FGF-23 concentrations were more frequent than hyperparathyroidism or hyperphosphatemia in this cohort. Serum creatinine and phosphorus concentrations were the strongest independent predictors of FGF-23 concentration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and clinical importance<\/jats:title>\n                    <jats:p>Plasma FGF-23 concentrations increase in dogs with CKD as disease progresses. Plasma FGF-23 concentrations appear to be useful for further study of the pathophysiology of CKD-MBD in dogs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.14707","type":"journal-article","created":{"date-parts":[[2017,4,17]],"date-time":"2017-04-17T07:36:41Z","timestamp":1492414601000},"page":"784-790","source":"Crossref","is-referenced-by-count":34,"title":["Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease"],"prefix":"10.1093","volume":"31","author":[{"given":"L.M.","family":"Harjes","sequence":"first","affiliation":[{"name":"Veterinary Clinical Sciences, The Ohio State University , Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6505-8068","authenticated-orcid":false,"given":"V.J.","family":"Parker","sequence":"additional","affiliation":[{"name":"Veterinary Clinical Sciences, The Ohio State University , Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Dembek","sequence":"additional","affiliation":[{"name":"Veterinary Clinical Sciences, The Ohio State University , Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.S.","family":"Young","sequence":"additional","affiliation":[{"name":"Center for Biostatistics, The Ohio State University , Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.H.","family":"Giovaninni","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Animal Science, University of S\u00e3o Paulo , S\u00e3o Paulo, SP,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Kogika","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Animal Science, University of S\u00e3o Paulo , S\u00e3o Paulo, SP,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Chew","sequence":"additional","affiliation":[{"name":"Veterinary Clinical Sciences, The Ohio State University , Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"Toribio","sequence":"additional","affiliation":[{"name":"Veterinary Clinical Sciences, The Ohio State University , Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,1]]},"reference":[{"key":"2026020303185040800_jvim14707-bib-0001","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2460\/javma.1999.214.09.1336","article-title":"Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States","volume":"214","author":"Lund","year":"1999","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303185040800_jvim14707-bib-0002","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.prevetmed.2010.01.007","article-title":"Disease surveillance and referral bias in the veterinary medical database","volume":"94","author":"Bartlett","year":"2010","journal-title":"Prev Vet Med"},{"key":"2026020303185040800_jvim14707-bib-0003","first-page":"115","article-title":"Veterinary Science: Current Aspects in Biology, Animal Pathology, clInic and Food Hygiene","author":"Guidi","year":"2012"},{"key":"2026020303185040800_jvim14707-bib-0004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1939-1676.2009.0415.x","article-title":"Calcium and phosphorus homeostasis in dogs with spontaneous chronic kidney disease at different stages of severity","volume":"24","author":"Cortadellas","year":"2010","journal-title":"J Vet Intern Med"},{"key":"2026020303185040800_jvim14707-bib-0005","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00467-009-1273-z","article-title":"Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): Implications for disorders of phosphate metabolism","volume":"25","author":"Gattineni","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"2026020303185040800_jvim14707-bib-0006","doi-asserted-by":"crossref","first-page":"F285","DOI":"10.1152\/ajprenal.00508.2009","article-title":"Phosphate homeostasis and the renal-gastrointestinal axis","volume":"299","author":"Marks","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026020303185040800_jvim14707-bib-0007","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jvim.13625","article-title":"Relationship between plasma fibroblast growth factor-23 concentration and survival time in cats with chronic kidney disease","volume":"29","author":"Geddes","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020303185040800_jvim14707-bib-0008","doi-asserted-by":"crossref","first-page":"e110057","DOI":"10.1371\/journal.pone.0110057","article-title":"The effect of naturally occurring chronic kidney disease on the micro-structural and mechanical properties of bone","volume":"9","author":"Shipov","year":"2014","journal-title":"PLoS ONE"},{"key":"2026020303185040800_jvim14707-bib-0009","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrneph.2013.147","article-title":"FGF-23 and secondary hyperparathyroidism in chronic kidney disease","volume":"9","author":"Silver","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"2026020303185040800_jvim14707-bib-0010","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2026020303185040800_jvim14707-bib-0011","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jvim.12036","article-title":"Fibroblast growth factor 23 (FGF-23) concentrations in cats with early nonazotemic chronic kidney disease (CKD) and in healthy geriatric cats","volume":"27","author":"Finch","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026020303185040800_jvim14707-bib-0012","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1744-9987.2005.00292.x","article-title":"Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23","volume":"9","author":"Miyamoto","year":"2005","journal-title":"Ther Apher Dial"},{"key":"2026020303185040800_jvim14707-bib-0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-09-0597","article-title":"Fibroblast growth factor 23 and its role in phosphate homeostasis","volume":"162","author":"Ramon","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2026020303185040800_jvim14707-bib-0014","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000346778","article-title":"Klotho and chronic kidney disease","volume":"180","author":"Hu","year":"2013","journal-title":"Contrib Nephrol"},{"key":"2026020303185040800_jvim14707-bib-0015","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"2026020303185040800_jvim14707-bib-0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000365787","article-title":"Fibroblast growth factor 23\/klotho axis in chronic kidney disease","volume":"128","author":"Nitta","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"2026020303185040800_jvim14707-bib-0017","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.14653","article-title":"Association of vitamin D metabolites with parathyroid hormone, fibroblast growth factor-23, calcium, and phosphorus in dogs with various stages of chronic kidney disease","author":"Parker","journal-title":"J Vet Intern Med"},{"key":"2026020303185040800_jvim14707-bib-0018","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cvsm.2010.09.004","article-title":"Chronic kidney disease in small animals","volume":"41","author":"Polzin","year":"2011","journal-title":"Vet Clin North Am"},{"key":"2026020303185040800_jvim14707-bib-0019","article-title":"Phosphatemia management in the treatment of chronic kidney disease, a roundtable discussion","author":"Vetoquinol","year":"2006"},{"key":"2026020303185040800_jvim14707-bib-0020","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"2026020303185040800_jvim14707-bib-0021","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2215\/CJN.08680811","article-title":"Combined use of vitamin D status and FGF23 for risk stratification of renal outcome","volume":"7","author":"Nakano","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026020303185040800_jvim14707-bib-0022","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/vec.12036","article-title":"Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease","volume":"23","author":"de Brito Galvao","year":"2013","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020303185040800_jvim14707-bib-0023","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.2460\/javma.241.10.1326","article-title":"Parathyroid hormone concentration in geriatric cats with various degrees of renal function","volume":"241","author":"Finch","year":"2012","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303185040800_jvim14707-bib-0024","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jvim.12044","article-title":"Fibroblast growth factor 23 in feline chronic kidney disease","volume":"27","author":"Geddes","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026020303185040800_jvim14707-bib-0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1590\/S0100-736X2013000200015","article-title":"Serum intact parathyroid hormone evaluation in cats with chronic kidney disease","volume":"33","author":"Giovaninni","year":"2013","journal-title":"Pesq Vet Bras"},{"key":"2026020303185040800_jvim14707-bib-0026","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/vr.157.12.344","article-title":"Diurnal variations in the plasma concentration of parathyroid hormone in dogs","volume":"157","author":"Lopez","year":"2005","journal-title":"Vet Rec"},{"key":"2026020303185040800_jvim14707-bib-0027","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/jvim.12187","article-title":"The effect of feeding a renal diet on plasma fibroblast growth factor 23 concentrations in cats with stable azotemic chronic kidney disease","volume":"27","author":"Geddes","year":"2013","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.14707","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/31\/3\/784\/66668495\/jvim14707.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/31\/3\/784\/66668495\/jvim14707.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:19:02Z","timestamp":1770106742000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/31\/3\/784\/8449386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,1]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.14707","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5]]},"published":{"date-parts":[[2017,5,1]]}}}